World Malaria Day – making world malaria free
Today is World Malaria Day. The day is observed every year to create awareness among the people about this vector borne disease. Within the next four years, six nations in
Malaria
Small bite, big threat
More than half the world’s population is at risk from diseases such as malaria, dengue, leishmaniasis, Lyme disease, schistosomiasis, and yellow fever, carried by mosquitoes, flies, ticks, water snails and
New potential Malaria treatment detected
Scientists have discovered a new molecules that can kill the malaria parasite, paving way for effective treatment for the disease. Using ultra sophisticated computerised modelling tools, researchers were successful in
Health Education & Research – new department in central govt.
Recognizing the role of scientific inputs for accessible and affordable healthcare programmes, Prime Minister Dr Manmohan Singh said that government has established a new department for Health Education and Research.
Travel medicine advises international travelers about health risks
Travel medicine or emporiatrics is the branch of medicine that deals with the prevention and management of health problems of international travelers. Globalization facilitates the spread of disease and increases
Nutrition is pre-requisite of Beauty
Nutrition is the pre-requisite of beauty. There is peaceful co-existence of Allopathy with Ayurveda, Yoga, Siddha and Sowa-Rigpa in our country, Union Minister of Health & Family Welfare, Shri Ghulam
Health :: UN-backed fund to fight major diseases approves $1.1 billion of new grants
The United Nations-backed Global Fund to Fight AIDS, Tuberculosis and Malaria approved $1.1 billion of new grants to be handed out over the next two years and agreed to allocate another $130 million to five projects it had already started supporting.
MRSA :: Factor key to severity of community-associated methicillin-resistant staph infections identified
Newly described proteins in drug-resistant strains of the Staphylococcus aureus bacterium attract and then destroy protective human white blood cells—a key process ensuring that S. aureus survives and causes severe disease, according to scientists at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.
Malaria :: Malaria vaccine candidate has promising safety, tolerability profile in infants
The first study to test GlaxoSmithKline’s (GSK) investigational RTS,S/AS02 malaria vaccine in African infants serves as the first proof of concept in this population that the vaccine has a promising safety and tolerability profile and reduces malaria parasite infection and clinical illness due to malaria, according to a paper published today online in The Lancet.
Mosquito :: MIT Holding, Georgia Southern University, and MEVLABS successfully test the PROVECTOR
MIT Holding, Inc. (OTCBB: MITD), in collaboration with MEVLABS and Georgia Southern University, have successfully tested prototype designs of the patent pending PROVECTOR™. This small dispensable device is designed to stop the development of pathogens and parasites found in mosquitoes that carry deadly diseases such as malaria, dengue fever, and West Nile virus.